Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CC-11050 for Erythema Nodosum Leprosum in Nepal
NCT03807362Phase 2Unknown
- Sponsor
- The Leprosy Mission Nepal
- Start
- Jan 2018
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dovramilast in erythema nodosum leprosum (ENL), sponsored by The Leprosy Mission Nepal. Status: unknown.
02
Drugs
dovramilast
03
Conditions
erythema nodosum leprosum (ENL)
Beyond the preview
Go deeper on NCT03807362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03807362.